Description
+ Include: videos + file sub vtt + pdf, size: GB
+ Target Audience: clinicians, researchers, and healthcare professionals who want to strengthen their expertise in preventing cardiovascular disease
+ Sample video: contact me for sample video
+ Information:
5th Annual Cardiovascular Disease (CVD) Prevention Symposium – April 11, 2026
Prevention of cardiovascular disease (heart attacks, heart failure, arrhythmias) is possible. Most cardiovascular diseases can be prevented when other risk factors, such as overweight or obesity, smoking, physical inactivity, high blood pressure, high cholesterol, and diabetes, are addressed. Early detection, lifestyle modification, and medicine management are key for addressing cardiovascular risk.
The number of patients with obesity, diabetes, and other risk factors continues to rise. Therefore, more emphasis needs to be on prevention, rather than reacting and managing cardiovascular diseases. This educational event will provide updates on the most current recommendations for cardiovascular disease prevention, ranging from lifestyle interventions, testing and clinical decision-making for physicians, physician assistants, nurse practitioners, residents, and fellows. Examples include diet, exercise and obesity-related guidelines (primary prevention), blood pressure management, cholesterol management, newer therapies for diabetes and chronic kidney disease.
Target Audience
Physicians, Physician Assistants, Nurse Practitioners, Nurses, Other Healthcare Professionals, Residents, Fellows, and Other Non-Healthcare Professionals
Learning Objectives
At the conclusion of this activity, the participant should be able to:
- Utilize the new guidelines to identify and mitigate risk factors for heart disease
- Discuss prevention strategies (primary and secondary) related to different patient populations
- Discuss the role of diagnostic and therapeutic interventions for prevention and treatment of common cardiovascular diseases as well as their risk factors
The Houston Methodist 5th Annual Cardiovascular Disease (CVD) Prevention Symposium 2026 is best for clinicians, researchers, and healthcare professionals who want to strengthen their expertise in preventing cardiovascular disease through evidence‑based, multidisciplinary strategies. It emphasizes risk reduction, lifestyle interventions, pharmacologic updates, and innovative approaches to population health.
👩⚕️ Target Audience
- Cardiologists & internists focusing on preventive cardiology.
- Primary care physicians & family medicine doctors managing cardiovascular risk factors in outpatient practice.
- Endocrinologists & metabolic specialists addressing diabetes, obesity, and lipid disorders.
- Nurse practitioners, physician associates, dietitians, and pharmacists working in cardiovascular prevention programs.
- Researchers & scientists studying cardiovascular epidemiology, genetics, and prevention strategies.
- Residents & fellows preparing for careers in cardiology or preventive medicine.
📚 What Participants Gain
- Risk factor management: hypertension, hyperlipidemia, diabetes, obesity, and smoking cessation.
- Lifestyle interventions: nutrition, exercise, and behavioral health integration.
- Pharmacologic updates: statins, PCSK9 inhibitors, GLP‑1 agonists, and emerging therapies.
- Population health strategies: screening, prevention programs, and health equity.
- Case‑based learning: practical scenarios for patient‑centered care.
- Guideline integration: latest evidence‑based standards for cardiovascular prevention.
+ Topics:
- 01 Obesity as a Disease – 2026 Updates
- 02 CVD Risk Stratification in 2026
- 03 Obesity Panel Q&A
- 04 Obesity Management Medications in 2026
- 05 Lipid Case and Panel Q&A
- 06 The 2026 ACC AHA Dyslipidemia Guideline – Updates
- 07 What’s New with Non-Statin LDL-C Lowering Therapies
- 08 CVD Risk Panel Q&A
- 09 Use of Blood, Imaging, and AI-based Biomarkers for CV Risk Assessment
- 10 Controlling Blood Pressure – Updated 2025 Guideline for High Blood Pressure
- 11 Therapies Promoting CKM Health – Lifestyle, New Medications, and Role for Procedures
- 12 Role of Renal Denervation in the Management of Hypertension
- 13 CKM Case and Panel Q&A
- 14 Hypertension Case and Panel Q&A
- 15 What is CKM Health, Syndrome, and Stages
Reviews
There are no reviews yet.